Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer

Clinical trial NCT06016179 · RECRUITING

Trial details

NCT number: NCT06016179
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Pleural Effusion Malignant Ascites

Start date: 2024-01-30
Primary completion: 2026-01-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.